phosphoribosyl-n-formylglycineamide has been researched along with hypoxanthine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barton, JW; Bleskan, J; Patterson, D | 1 |
| Hurlbert, RB; Massia, SP; Moore, EC | 1 |
| Adamson, DJ; Bennett, LL; Brockman, RW; Rose, LM; Smithers, D | 1 |
3 other study(ies) available for phosphoribosyl-n-formylglycineamide and hypoxanthine
| Article | Year |
|---|---|
Isolation of a human cDNA encoding amidophosphoribosyltransferase and functional complementation of a CHO Ade-A mutant deficient in this activity.
Topics: Amidophosphoribosyltransferase; Animals; Cricetinae; Cricetulus; DNA; Genetic Complementation Test; Genetic Markers; Glycine; Humans; Hypoxanthine; Hypoxanthines; Liver Neoplasms, Experimental; Mutation; Ribonucleotides; RNA, Messenger; Saccharomyces cerevisiae; Tumor Cells, Cultured | 1991 |
Inhibition of CCRF-CEM human leukemic lymphoblasts by triciribine (tricyclic nucleoside, TCN, NSC-154020). Accumulation of drug in cells and comparison of effects on viability, protein synthesis and purine synthesis.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Cell Survival; Formates; Glycine; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; Kinetics; Leukemia, Lymphoid; Lymphocytes; Phosphorylation; Protein Biosynthesis; Purines; Ribonucleosides; Ribonucleotides; RNA; Tumor Cells, Cultured | 1989 |
Mode of action of 2-amino-6-chloro-1-deazapurine.
Topics: 2-Aminopurine; Adenine; AMP Deaminase; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line; Cell Survival; Glycine; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Laryngeal Neoplasms; Leukemia L1210; Macromolecular Substances; Mice; Nucleotides; Ribonucleotides; Structure-Activity Relationship | 1984 |